Data Management
Written by: CDO Magazine
Updated 1:02 PM EST, November 12, 2026
For a healthcare distribution company, trusted data has consequences that extend beyond reporting and analytics. Data accuracy and reliability affect medicine delivery, business decisions and the outcomes organizations expect from AI. In Cencora’s operations, the connection is particularly clear.
In the first installment of a three-part CDO Magazine interview series, Jig Patel, SVP, Enterprise Data, Analytics & AI at Cencora, speaks with Gorkem Sevinc, Co-founder and CEO of Qualytics, about the growing importance of trusted data across healthcare operations. Patel explains how data has evolved from a supporting component of business solutions into an asset that informs decisions and supports the organization’s progression from traditional machine learning to generative and agentic AI.
Patel shares examples of how trusted data connects directly to Cencora’s purpose of creating healthier futures. The company delivers approximately five million pharmaceutical products daily, with 80 percent reaching destinations within 12 hours. Patel also discusses the use of 550 million retina images at Retina Consultants of America to help identify clinical trial candidates and improve treatment efficacy.
The conversation also explores how changing data consumption is reshaping business operations. Finance teams have moved toward real-time querying and analysis, while Cencora is shifting its approach from traditional business intelligence toward AI-powered insights.
Key topics include:
On the move? Take this conversation with you. If you don’t have time to finish the video, you can stream the complete, uninterrupted audio edition of this episode on the go.